The cyclooxygenase-2 inhibitor parecoxib inhibits surgery-induced proinflammatory cytokine expression in the hippocampus in aged rats

Journal of Surgical Research

Volumn 178, Issue 1, 2012, Pages e1-

  Peng, Mian ^a   Wang, Yan Lin ^a   Wang, Fei Fei ^a   Chen, Chang ^a   Wang, Cheng Yao ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

COX 2; Cytokines; Hippocampus; Neuroinflammation; Parecoxib

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; ISOFLURANE; MESSENGER RNA; PARECOXIB; PROSTAGLANDIN E2; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HIPPOCAMPUS; MALE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STRESS;

EID: 84868200581     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.08.030     Document Type: Article

References (46)

1. J.T. Moller, P. Cluitmans, and L.S. Rasmussen Long-term postoperative dysfunction in the elderly: ISPOCD 1 study Lancet 351 1998 857
2. L.S. Rasmussen Postoperative cognitive dysfunction: incidence and prevention Best Pract Res Clin Anaesthesiol 20 2006 315
3. M.F. Newman, J.L. Kirchner, B. Phillips-Bute Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery N Engl J Med 344 2001 395
4. J. Steinmetz, K.B. Christensen, T. Lund, N. Lohse, L.S. Rasmussen ISPOCD Group Long-term consequences of postoperative cognitive dysfunction Anesthesiology 110 2009 548
5. Y. Beloosesky, D. Hendel, and A. Weiss Cytokines and C-reactive protein production in hip-fracture-operated elderly patients J Gerontol A Biol Sci Med Sci 62 2007 420
6. A. Buvanendran, J.S. Kroin, and R.A. Berger Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans Anesthesiology 104 2006 403
7. X.Z. Cao, H. Ma, and J.K. Wang Postoperative cognitive deficits and neuroinflammation in the hippocampus triggered by surgical trauma are exacerbated in aged rats Prog Neuropsychopharmacol Biol Psychiatry 34 2010 1426
8. M. Cibelli, A.R. Fidalgo, and N. Terrando Role of interleukin-1beta in postoperative cognitive dysfunction Ann Neurol 68 2010 360
9. J. Kálmán, A. Juhász, and G. Bogáts Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline Neurochem Int 48 2006 177
10. H.A. Rosczyk, N.L. Sparkman, and R.W. Johnson Neuroinflammation and cognitive function in aged mice following minor surgery Exp Gerontol 43 2008 840
11. N. Terrando, C. Monaco, D. Ma, B.M. Foxwell, M. Feldmann, and M. Maze Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline Proc Natl Acad Sci U S A 107 2010 20518
12. N. Terrando, L.I. Eriksson, and J.K. Ryu Resolving postoperative neuroinflammation and cognitive decline Ann Neurol 70 2011 986
13. Y. Wan, J. Xu, D. Ma, Y. Zeng, M. Cibelli, and M. Maze Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus Anesthesiology 106 2007 436
14. J.R. Vane, Y.S. Bakhl, and R.M. Botting Cyclooxygenases 1 and 2 Annu Rev Pharmacol Toxicol 38 1998 97
15. Y. Kobayashi, T. Mizoguchi, I. Take, S. Kurihara, N. Udagawa, and N. Takahashi Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1 J Biol Chem 280 2005 11395
16. H.R. Herschman Prostaglandin synthesis 2 Biochim Biophys Acta 1229 1996 125
17. P.L. McGeer, and E.G. McGeer Inflammation and the degenerative disease of aging Ann N Y Acad Sci 1035 2004 104
18. L. Minghetti Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases J Neuropathol Exp Neurol 63 2004 901
19. L. Minghetti Role of COX-2 in inflammatory and degenerative brain diseases Subcell Biochem 42 2007 127
20. A.B. Reksidler, M.M. Lima, and S.M. Zanata The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats Eur J Pharmacol 560 2007 163
21. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402
22. T. Melnikova, A. Savonenko, and Q. Wang Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern Neuroscience 141 2006 1149
23. T.G. Monk, B.C. Weldon, and C.W. Garvan Predictors of cognitive dysfunction after major noncardiac surgery Anesthesiology 108 2008 18
24. D.J. Culley, M. Baxter, R. Yukhananov, and G. Crosby The memory effects of general anesthesia persist for weeks in young and aged rat Anesth Analg 96 2003 1004
25. K. Matsuda, S. Nakamura, and T. Matsushita Dynastat inhibits nitric oxide production in chondrocytes of ligament-damaged osteoarthritic rat joints Rheumatol Int 26 2006 991
26. B.J. Votta, and D.R. Bertolini Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro Bone 15 1994 533
27. J.J. Hoozemans, R. Veerhuis, I. Janssen, E.J. van Elk, A.J. Rozemuller, and P. Eikelenboom The role of cyclooxygenase 1 and 2 activity in prostaglandin E2 secretion by cultured human adult microglia: implications for Alzheimer's disease Brain Res 951 2002 218
28. P. Teismann, K. Tieu, and D.K. Choi Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration Proc Natl Acad Sci U S A 100 2003 5473
29. M.K. McCoy, T.N. Martinez, and K.A. Ruhn Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease J Neurosci 37 2006 9365
30. S. Aid, R. Langenbach, and F. Bosetti Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2 J Neuroinflammation 5 2008 17
31. V. Blais, N.P. Turrin, and S. Rivest Cyclooxygenase 2 (COX-2) inhibition increases the inflammatory response in the brain during systemic immune stimuli J Neurochem 95 2005 1563
32. M. Pickering, D. Cumiskey, and J.J. O'Connor Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system Exp Physiol 90 2005 663
33. V.H. Perry, C. Cunningham, and C. Holmes Systemic infections and inflammation affect chronic neurodegeneration Nat Rev Immunol 7 2007 161
34. S. Tanaka, M. Ide, and T. Shibutani Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats J Neurosci Res 83 2006 557
35. N.L. Sparkman, R.A. Kohman, V.J. Scott, and G.W. Boehm Bacterial endotoxin-induced behavioral alterations in two variations of the Morris water maze Physiol Behav 86 2005 244
36. G. Dembo, S.B. Park, and E.D. Kharasch Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans Anesthesiology 102 2005 409
37. V. Mehta, A. Johnston, R. Cheung, A. Bello, and R.M. Langford Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system Clin Pharmacol Ther 83 2008 430
38. A.V. Yermakova, J. Rollins, L.M. Callahan, J. Rogers, and M.K. O'Banion Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons J Neuropathol Exp Neurol 58 1999 1135
39. J. Rogers, L.C. Kirby, and S.R. Hempelman Clinical trial of indomethacin in Alzheimer's disease Neurology 43 1993 1609
40. J. Tang, S. Li, and P.F. White Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control Anesthesiology 96 2002 1305
41. T.P. Malan Jr., G. Marsh, S.I. Hakki, E. Grossman, L. Traylor, and R.C. Hubbard Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty Anesthesiology 98 2003 950
42. P.J. Desjardins, E.H. Grossman, and M.E. Kuss The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively Anesth Analg 93 2001 721
43. T.J. Gan, G.P. Joshi, S.Z. Zhao, D.B. Hanna, R.Y. Cheung, and C. Chen Presurgical intravenous parecoxib sodium and follow-up oral valdecoxib for pain management after laparoscopic cholecystectomy surgery reduces opioid requirements and opioid-related adverse effects Acta Anaesthesiol Scand 48 2004 1194
44. T.J. Gan, G.P. Joshi, and E. Viscusi Preoperative parenteral parecoxib and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgery Anesth Analg 98 2004 1665
45. P. Bajaj, C.C. Ballary, N.A. Dongre, V.P. Baliga, and A.A. Desai Role of parecoxib in pre-emptive analgesia: comparison of the efficacy and safety of pre- and postoperative parecoxib in patients undergoing general surgery J Indian Med Assoc 102 2004 272
46. H. Neuss, G. Koplin, O. Haase, C. Reetz, and J.W. Mall Preemptive analgesia reduces pain after radical axillary lymph node dissection J Surg Res 162 2010 88